ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro (Q36329991)

13 August 2017

ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro (English)

1 reference

13 August 2017

Brownlie RP

1

1 reference

13 August 2017

Brownrigg NJ

2

1 reference

13 August 2017

Butcher HM

3

1 reference

13 August 2017

Garcia R

4

1 reference

13 August 2017

Jessup R

5

1 reference

13 August 2017

Lee VJ

6

1 reference

13 August 2017

Tunstall S

7

1 reference

13 August 2017

Wayne MG

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

British Journal of Pharmacology

13 August 2017

1 reference

13 August 2017

110

1 reference

13 August 2017

4

1 reference

13 August 2017

1600-1606

1 reference

Some quantitative uses of drug antagonists

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

CGS 12970: a novel, long acting thromboxane synthetase inhibitor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Studies on the characterisation of prostanoid receptors: a proposed classification

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Pharmacological actions of ICI 180080, a novel thromboxane receptor antagonist

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175849

Thromboxane synthase as a cytochrome P450 enzyme

5 December 2018

1 reference

12 December 2020

Effects of vascular trauma and transient myocardial ischaemia on coronary venous prostaglandin levels in the dog

1 reference

12 December 2020

Measurement OF Human venous plasma prostacyclin and metabolites by radioimmunoassay: A reappraisal

1 reference

12 December 2020

Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets

1 reference

12 December 2020

Thromboxane synthase inhibition: implications for prostaglandin endoperoxide metabolism. I. Characterisation of an acute intravenous challenge model to measure prostaglandin endoperoxide metabolism

1 reference

12 December 2020

CV-4151--a potent, selective thromboxane A2 synthetase inhibitor

1 reference

12 December 2020

Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo

1 reference

12 December 2020

Effect of platelet activating factor on leukocyte-endothelial cell interactions

1 reference

12 December 2020

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro

1 reference

12 December 2020

Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression

1 reference

12 December 2020

Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin

1 reference

12 December 2020

Urinary excretion of throm☐ane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary throm☐ane B2 and 6-keto-prostaglandin F1α in healthy subjects

1 reference

12 December 2020

10.1111/J.1476-5381.1993.TB14007.X

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

8306107

1 reference